What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings

Journal of General Internal Medicine

Volumn 23, Issue 9, 2008, Pages 1435-1440

  Gellad, Walid F ^a   Schneeweiss, Sebastian ^a   Brawarsky, Phyllis ^a   Lipsitz, Stuart ^a   Haas, Jennifer S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Costs of care; Medicare; Pharmaceuticals

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DRUG COST; DRUG FORMULATION; DRUG UTILIZATION; GOVERNMENT; HEALTH SURVEY; PRESCRIPTION;

AGED; AGED, 80 AND OVER; COST SAVINGS; CROSS-SECTIONAL STUDIES; FEES, PHARMACEUTICAL; FEMALE; HUMANS; MALE; MEDICARE PART D; NEGOTIATING; UNITED STATES;

EID: 50049115248     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0689-7     Document Type: Article

References (28)

1. Medicare program 2005 Medicare prescription drug benefit. Final rule Fed Regist 70 18 4193 4585
2. Kaiser Family Foundation/Harvard School of Public Health. Seniors and the medicare prescription drug benefit; December 2006.
3. JM Madden AJ Graves F Zhang 2008 Cost-related medication nonadherence and spending on basic needs following implementation of medicare part D JAMA 299 16 1922 1928
4. DP Goldman GF Joyce 2008 Medicare part D: a successful start with room for improvement JAMA 299 16 1954 1955
5. RG Frank JP Newhouse 2008 Should drug prices be negotiated under part d of Medicare? and if so, how? Health Affairs 27 1 33 43
6. Steinberg M, Bailey K. No Bargain: Medicare Drug Plans Deliver High Prices. Washington, D.C.: Families USA; 2007 January.
7. Testimony of Richard G Frank, Ph.D. In: US Senate Committee on Finance. Washington, D.C.; January 11, 2007.
8. Congressional Budget Office. Prices for Brand-Name Drugs Under Selected Federal Programs: The Congress of the United States; 2005, June.
9. C Smith C Cowan S Heffler A Catlin 2006 National health spending in 2004: recent slowdown led by prescription drug spending Health Aff (Millwood) 25 1 186 196
10. JS Haas KA Phillips EP Gerstenberger AC Seger 2005 Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000 Ann Intern Med 142 11 891 897
11. Moeller JF, Stagnitti MN, Horan E, Ward P, Kieffer N, Hock E. Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Panel Survey (HC-010A). Rockville, MD: Agency for Healthcare Research and Quality; 2001.
12. Consumer Price Index.: Federal Reserve Bank of Minneapolis.
13. Centers for Medicare and Medicaid Services. 2004 National Health Expenditures Accounts. Available at http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/2004-age-tables.pdf. Accessed May 10, 2008.
14. A Hollis 2004 How cheap are Canada's drugs really? J Pharm Sci 7 2 215 216
15. Anderson GF, Shea DG, Hussey PS, Keyhani S, Zephyrin L. Doughnut holes and price controls. Health Aff (Millwood). 2004:W4-396-404. Suppl Web Exclusives.
16. BS Quon R Firszt MJ Eisenberg 2005 A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major US drug chain pharmacies Ann Intern Med 143 6 397 403
17. D'Angelo G, Moffit RE. H.R. 4: A Confusing and Contradictory Prescription for Medicare Drugs. Washington, DC: The Heritage Foundation; 2007January 11.
18. Enthoven A, Fong K. Medicare: Negotiated Drug Prices May Not Lower Costs. Dallas, TX: National Center for Policy Analysis; 2006 December 18.
19. Testimony of Richard G Frank, Ph.D. In: US Senate Committee on Finance. Washington, D.C.; January 11, 2007.
20. Holtz-Eakin D. Letter to Senator Ron Wyden, United States Senate; March 3, 2004.
21. Centers for Medicare and Medicaid Services. Drug Plan Finder Analysis: Medicare PDP Savings Compared to Cash Prices. October 12, 2006. Available at http://www.cms.hhs.gov/prescriptiondrugcovgenIn/downloads/planfinderanalysis. pdf. Accessed May 1, 2008.
22. A Catlin C Cowan M Hartman S Heffler 2008 National health spending in 2006: a year of change for prescription drugs Health Aff (Millwood) 27 1 14 29
23. United States General Accounting Office. Drug Prices: Effects of Opening Federal Supply Schedule for Pharmaceuticals are Uncertain; June 1997.
24. Mahan D. Sticker Shock: Rising Prescription Drug Prices for Seniors. Washington, DC: Families USA; 2004 June.
25. Weisman J. Costs Grow for Common Medicare Drugs. Washington Post 2007 Sunday, May 13;Sect. A10.
26. Department of Health and Human Services. Report to the President: Prescription Drug Coverage, Spending, Utilization, and Prices. April 2000. Available at http://aspe.hhs.gov/health/reports/drugstudy. Accessed May 1, 2008.
27. Poisal JA, Truffer C, Smith S, et al. Health spending projections through 2016: modest changes obscure part D's impact. Health Aff (Millwood) 2007.
28. SH Zuvekas JW Cohen 2007 Prescription drugs and the changing concentration of health care expenditures Health Aff (Millwood) 26 1 249 257